A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
about
In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasisA humanized mouse model of tuberculosisEstablishment and validation of whole-cell based fluorescence assays to identify anti-mycobacterial compounds using the Acanthamoeba castellanii-Mycobacterium marinum host-pathogen systemIn vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system.Real-time bioluminescence imaging of mixed mycobacterial infectionsIdentification of the translational start site of codon-optimized mCherry in Mycobacterium tuberculosisSynthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis.Tuberculosis vaccine development: Shifting focus amid increasing development challenges.Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo.Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosisRapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.Elucidating population-wide mycobacterial replication dynamics at the single-cell levelNoninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713.A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry.The granuloma in tuberculosis: dynamics of a host-pathogen collusion.Noninvasive fluorescence imaging of small animals.Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives.The application of anti-ESAT-6 monoclonal antibody fluorescent probe in ex vivo near-infrared fluorescence imaging in mice with pulmonary tuberculosis.Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB.Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII8-12.Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence.Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis.
P2860
Q27305075-64C93CE3-3FB5-4EF7-9285-8F389913AF11Q27320865-006CA190-09FD-4C7A-9079-53A70E4AA84FQ28539402-CD24A78A-D12A-4BF7-BAB6-F6AAAA61394EQ33798263-7BF1F92D-2C59-44A0-AE32-9D379510C558Q34268825-D5CD20E2-580A-4394-891E-335B021E0FD2Q35189214-54AA05CC-4243-494E-9A37-819F421EFD54Q36037140-FF683843-5211-49C2-8F3C-1B3E36045F30Q36256304-020E42FB-4BF7-4EFA-ADB7-265D31EC983DQ36641623-8054B5CB-DEB9-4D4A-A962-499D5D66AC85Q36933343-A040CB09-3256-4CB3-9EAC-6C5D93BD5832Q37095473-34BF2223-6083-4D66-895F-83175D1FA148Q37295982-4B84EBCA-A01A-4C7F-8283-5E5D17B1C8B9Q37332188-47E16B7B-158E-449C-8628-E0A1DE66AA2AQ37516443-CF0A723E-54B3-4957-B7B1-BC7DDE9582A8Q38073249-39DAF143-A43F-44D9-AB22-B386A49512B0Q38120583-8A024FD8-487D-42A2-8C60-9263B484F7C0Q38221214-46A0E5A5-D958-4045-A5CD-AC43443B61CAQ38767138-29AB4619-F93E-4C1E-AE20-4D15E6D98D26Q38878582-56155907-E270-4A8B-A37B-D7571E27226FQ43526589-D8C1571A-0931-4C4E-BC54-A3DB07FC1E4EQ47138047-C9992926-CC73-4FCB-B1DC-2C674DF3D922Q50087921-574C18D2-DA2F-4B40-BDE5-EF915C2ECBBCQ52649036-D86D08E9-CBBD-4CB8-8115-051BA36C6C36Q55514236-51DB93B0-34C5-469B-BC01-779058E829FA
P2860
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@ast
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@en
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@nl
type
label
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@ast
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@en
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@nl
prefLabel
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@ast
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@en
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@nl
P2093
P2860
P50
P356
P1476
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
@en
P2093
Andrea Zelmer
Gregory J Bancroft
Jacqueline Mahlo
Kristine Hagens
Natalja Redinger
Paul Carroll
Tanya Parish
Ulrich E Schaible
P2860
P304
P356
10.1093/JAC/DKS161
P407
P577
2012-05-25T00:00:00Z